Yipeng Xu

518 total citations
32 papers, 348 citations indexed

About

Yipeng Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Yipeng Xu has authored 32 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Yipeng Xu's work include Prostate Cancer Treatment and Research (7 papers), Ferroptosis and cancer prognosis (3 papers) and Epigenetics and DNA Methylation (3 papers). Yipeng Xu is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Ferroptosis and cancer prognosis (3 papers) and Epigenetics and DNA Methylation (3 papers). Yipeng Xu collaborates with scholars based in China, Germany and France. Yipeng Xu's co-authors include Shaoxing Zhu, Zongping Wang, Cheng-Yi Liu, Mei Song, Xu Yang, Maïté Marquine, Cheng Qiao, Michel Raymond, Zihao Chen and Feng Cui and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Environmental Science & Technology.

In The Last Decade

Yipeng Xu

29 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yipeng Xu China	12	159	71	65	55	36	32	348
Jufang Chi China	15	288 1.8×	86 1.2×	77 1.2×	79 1.4×	47 1.3×	26	579
Thomas Ntounis Greece	8	199 1.3×	65 0.9×	56 0.9×	86 1.6×	27 0.8×	25	373
Xiaogang Sun China	10	180 1.1×	112 1.6×	46 0.7×	95 1.7×	37 1.0×	14	376
So Jung Kim South Korea	11	243 1.5×	88 1.2×	85 1.3×	25 0.5×	36 1.0×	33	520
Lu Zhao China	14	288 1.8×	50 0.7×	57 0.9×	86 1.6×	55 1.5×	46	546
Wenqi Shan China	14	248 1.6×	51 0.7×	35 0.5×	80 1.5×	54 1.5×	23	458
Qiuyun Guo China	9	157 1.0×	56 0.8×	59 0.9×	57 1.0×	31 0.9×	13	309
Richa Pant India	9	204 1.3×	72 1.0×	51 0.8×	67 1.2×	42 1.2×	16	403
Tatiane De Rossi Brazil	7	179 1.1×	118 1.7×	42 0.6×	88 1.6×	29 0.8×	11	440

Countries citing papers authored by Yipeng Xu

Since Specialization

Citations

This map shows the geographic impact of Yipeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yipeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yipeng Xu more than expected).

Fields of papers citing papers by Yipeng Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yipeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yipeng Xu. The network helps show where Yipeng Xu may publish in the future.

Co-authorship network of co-authors of Yipeng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yipeng Xu. A scholar is included among the top collaborators of Yipeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yipeng Xu. Yipeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Yipeng, et al.. (2025). Mefloquine Suppresses Metastasis in Renal Cell Carcinoma Through Targeting SPC25. Cancer Science. 116(5). 1239–1254.

Fang, Chenyan, et al.. (2025). Comprehensive review on Fanconi anemia: insights into DNA interstrand cross-links, repair pathways, and associated tumors. Orphanet Journal of Rare Diseases. 20(1). 389–389.

Xu, Yipeng, et al.. (2025). Synergizing metabolomics and artificial intelligence for advancing precision oncology. Trends in Molecular Medicine. 31(8). 692–701. 4 indexed citations

Xu, Yipeng, Yu Fang, Pei Yu, et al.. (2024). Clinical efficacy of DSA-based features in predicting outcomes of acupuncture intervention on upper limb dysfunction following ischemic stroke. Chinese Medicine. 19(1). 155–155. 1 indexed citations

Shi, Xiaoliang, et al.. (2024). Pharmacogenomics assists in controlling blood pressure in cardiovascular and cerebrovascular patients during Rehabilitation: a case report. Frontiers in Pharmacology. 15. 1424683–1424683. 1 indexed citations

Jia, Xiaoyuan, Yujia Zhao, Xiaoyan Wang, et al.. (2024). Targeted Inhibition of p21 Promotes the Growth of Breast Cancer Cells and Impairs the Tumor-Killing Effect of the Vaccinia Virus. Journal of Breast Cancer. 27(5). 293–293. 1 indexed citations

Zhao, Jiahui, Yipeng Xu, Yingjie Luo, et al.. (2023). Uncovering SOD3 and GPX4 as new targets of Benzo[α]pyrene-induced hepatotoxicity through Metabolomics and Chemical Proteomics. Redox Biology. 67. 102930–102930. 17 indexed citations

Zhu, Shaoxing, et al.. (2023). Autophagy-related gene LAPTM4B promotes the progression of renal clear cell carcinoma and is associated with immunity. Frontiers in Pharmacology. 14. 1118217–1118217. 7 indexed citations

Xu, Yipeng, et al.. (2022). IC50: an unsuitable measure for large-sized prostate cancer spheroids in drug sensitivity evaluation. SHILAP Revista de lepidopterología. 22(4). 580–592. 10 indexed citations

10.

Zhang, Haoran, Lu Zhang, Yipeng Xu, et al.. (2022). Simulating androgen receptor selection in designer yeast. Synthetic and Systems Biotechnology. 7(4). 1108–1116. 3 indexed citations

11.

Luo, Yi, Tian Tian, Xu Chen, et al.. (2022). RNF4 controls the extent of replication fork reversal to preserve genome stability. Nucleic Acids Research. 50(10). 5672–5687. 15 indexed citations

12.

Xu, Yipeng, Reinhold Schäfer, Yingying Cui, et al.. (2022). Evaluation of JQ1 Combined With Docetaxel for the Treatment of Prostate Cancer Cells in 2D- and 3D-Culture Systems. Frontiers in Pharmacology. 13. 839620–839620. 11 indexed citations

13.

Xu, Yipeng, et al.. (2021). Optimal Method of Electrical Stimulation for the Treatment of Upper Limb Dysfunction After Stroke: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Controlled Trials. Neuropsychiatric Disease and Treatment. Volume 17. 2937–2954. 20 indexed citations

14.

Xu, Yipeng, Xu Han, Yun Gao, et al.. (2021). Urinary Exosomes Diagnosis of Urological Tumors: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 11. 734587–734587. 6 indexed citations

15.

Liu, Chengyi, et al.. (2019). Malignant ureteral obstruction: experience and comparative analysis of metallic versus ordinary polymer ureteral stents. World Journal of Surgical Oncology. 17(1). 74–74. 25 indexed citations

16.

Shen, Yuehong, Fei Yang, Hua Wang, et al.. (2016). Arg-Gly-Asp (RGD)-Modified E1A/E1B Double Mutant Adenovirus Enhances Antitumor Activity in Prostate Cancer Cells In Vitro and in Mice. PLoS ONE. 11(1). e0147173–e0147173. 15 indexed citations

17.

Xu, Yipeng, Hua Wang, Zongping Wang, et al.. (2015). Diagnosis and treatment of penile verrucous carcinoma. Oncology Letters. 9(4). 1687–1690. 9 indexed citations

18.

Xu, Yipeng, Shaoxing Zhu, Mei Song, et al.. (2014). B7-H4 expression and its role in interleukin-2/interferon treatment of clear cell renal cell carcinoma. Oncology Letters. 7(5). 1474–1478. 21 indexed citations

19.

Liu, Cheng-Yi, et al.. (2013). Roles of autophagy-related genes Beclin-1 and LC3 in the development and progression of prostate cancer and benign prostatic hyperplasia. Biomedical Reports. 1(6). 855–860. 43 indexed citations

20.

Xu, Yipeng & Shaoxing Zhu. (2013). Associations between vascular endothelial growth factor polymorphisms and prostate cancer risk: a meta-analysis. Tumor Biology. 35(2). 1307–1311. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact